+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Myocardial Infarction Drug"

Myocardial Infarction (MI) Treatment - Global Strategic Business Report - Product Thumbnail Image

Myocardial Infarction (MI) Treatment - Global Strategic Business Report

  • Report
  • March 2025
  • 296 Pages
  • Global
From
Myocardial Infarction - Pipeline Insight, 2024 - Product Thumbnail Image

Myocardial Infarction - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 180 Pages
  • Global
From
Myocardial Infarction (MI) Therapeutics Market 2024-2028 - Product Thumbnail Image

Myocardial Infarction (MI) Therapeutics Market 2024-2028

  • Report
  • October 2024
  • 149 Pages
  • Global
From
Reteplase Market by Patient Type (Adult, Geriatric, Pediatric), Therapeutic Area (Acute Myocardial Infarction, Pulmonary Embolism), Distribution Channel, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Reteplase Market by Patient Type (Adult, Geriatric, Pediatric), Therapeutic Area (Acute Myocardial Infarction, Pulmonary Embolism), Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • March 2025
  • 197 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs - Global Strategic Business Report - Product Thumbnail Image

Ischemic Heart Disease (IHD) Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 194 Pages
  • Global
From
Anti-Ischemic Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Ischemic Agents - Global Strategic Business Report

  • Report
  • March 2025
  • 94 Pages
  • Global
From
Myocardial Infarction Market Report 2025 - Product Thumbnail Image

Myocardial Infarction Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Heparin Market 2025-2033 - Product Thumbnail Image

Heparin Market 2025-2033

  • Report
  • March 2025
  • 145 Pages
  • Global
From
Anticoagulants Market Report by Drug Class, and Region 2024-2032 - Product Thumbnail Image

Anticoagulants Market Report by Drug Class, and Region 2024-2032

  • Report
  • August 2024
  • 143 Pages
  • Global
From
Myocardial Infarction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Myocardial Infarction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 137 Pages
  • Global
From
CSL112 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

CSL112 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
FDY-5301 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

FDY-5301 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Selatogrel Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Selatogrel Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Olpasiran Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Olpasiran Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Pelacarsen Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Pelacarsen Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Anticoagulants Market Size, Share & Trends Analysis Report By Route of Administration (Oral Anticoagulants, Injectable Anticoagulants), By Drug Category, By Application (Atrial fibrillation, Pulmonary embolism), By Region, And Segment Forecasts, 2024 - 2030 - Product Thumbnail Image

Anticoagulants Market Size, Share & Trends Analysis Report By Route of Administration (Oral Anticoagulants, Injectable Anticoagulants), By Drug Category, By Application (Atrial fibrillation, Pulmonary embolism), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • February 2024
  • 125 Pages
  • Global
From
Japan CL2020 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Japan CL2020 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Japan
From
Myocardial Infarction Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Myocardial Infarction Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Myocardial Infarction - Epidemiology Forecast - 2032 - Product Thumbnail Image

Myocardial Infarction - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 110 Pages
  • Global
From
Global Acute Myocardial Infarction Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Acute Myocardial Infarction Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Loading Indicator

The Myocardial Infarction Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat and prevent heart diseases. Myocardial Infarction Drugs are used to treat acute myocardial infarction (AMI), also known as a heart attack. These drugs are used to reduce the risk of death and complications from AMI, such as heart failure, arrhythmias, and stroke. Commonly used Myocardial Infarction Drugs include anticoagulants, antiplatelet agents, beta-blockers, and statins. These drugs are used to reduce the risk of blood clots, reduce inflammation, and lower cholesterol levels. Some companies in the Myocardial Infarction Drug market include Pfizer, Merck, Sanofi, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more